W304409

L-(+)-Tartaric acid

≥99.7%, FCC, FG

• Synonyme(s) : (2R,3R)-(+)-Tartaric acid, L-Threaric acid
• Formule linéaire : HO₂CCH(OH)CH(OH)CO₂H
• Numéro CAS: 87-69-4
• Poids moléculaire : 150.09
• Numéro FEMA: 3044
• Numéro Beilstein : 1725147
• Numéro CE : 201-766-0
• Conseil de l'Europe Nº : 18
• Numéro MDL: MFCD00064207
• Code UNSPSC : 12164502
• ID de substance PubChem : 24901442
• Numéro Flavis : 8.018
• Nomenclature NACRES : NA.21

Propriétés

• Source biologique: synthetic
• Niveau de qualité: 400
• Qualité: FG; Halal
• Agence: meets purity specifications of JECFA
• Conformité réglementaire: EU Regulation 1334/2008 & 178/2002; FCC; FDA 21 CFR 163.110; FDA 21 CFR 163.111; FDA 21 CFR 163.112; FDA 21 CFR 184.1099
• Densité de vapeur: 5.18 (vs air)
• Pureté: ≥99.7%
• Forme: crystalline powder
• Activité optique: [α]20/D +12.5°, c = 20 in H₂O
• Température d'inflammation spontanée: 797 °F
• Pf: 170-172 °C (lit.)
• Solubilité: water: soluble 150 g/L at 25 °C
• Traces de cations: As: ≤3 ppm; Cd: ≤1 ppm; Hg: ≤1 ppm; heavy metals (as Pb): ≤2 ppm
• Application(s): flavors and fragrances
• Documentation: see Safety & Documentation for available documents
• Allergène alimentaire: no known allergens
• Propriétés organoleptiques: odorless
• Chaîne SMILES: O[C@H]([C@@H](O)C(O)=O)C(O)=O
• InChI: 1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2-/m1/s1
• Clé InChI: FEWJPZIEWOKRBE-JCYAYHJZSA-N

Description

Description générale

L-(+)-Tartaric acid is an organic acid commonly used as an acidulant, flavor enhancer, firming agent and humectant.

Application

• Terahertz-spectroscopy for non-destructive determination of crystallinity of L-tartaric acid in smartFilms and tablets made from paper.: This study leverages terahertz spectroscopy to assess the crystallinity of L-(+)-tartaric acid in innovative pharmaceutical applications, enhancing non-destructive testing methods for quality control (Ornik et al., 2020 May). Link to the article.


• Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations.: Research shows the use of L-(+)-tartaric acid in cocrystal formulations with itraconazole to improve its pulmonary absorption, demonstrating a significant advancement in drug delivery technologies (Karashima et al., 2017 Jun). Link to the article.


• Physicochemical Evaluation and Developability Assessment of Co-amorphouses of Low Soluble Drugs and Comparison to the Co-crystals.: This article discusses the role of L-(+)-tartaric acid in enhancing the solubility and bioavailability of pharmaceuticals through co-amorphous systems, offering a critical insight into drug formulation strategies (Yamamoto et al., 2016 Dec). Link to the article.


• Functionalized polycarbonate derived from tartaric acid: enzymatic ring-opening polymerization of a seven-membered cyclic carbonate.: This research explores the synthesis of biodegradable polymers from L-(+)-tartaric acid, emphasizing its utility in developing environmentally friendly materials (Wu et al., 2008 Oct). Link to the article.

Informations sur la sécurité

• Pictogrammes: GHS05
• Mention d'avertissement: Danger
• Mentions de danger: H318
• Conseils de prudence: P280 - P305 + P351 + P338
• Classification des risques: Eye Dam. 1
• Code de la classe de stockage: 11 - Combustible Solids
• Classe de danger pour l'eau (WGK): WGK 1
• Point d'éclair (°F): 302.0 °F - closed cup
• Point d'éclair (°C): 150 °C - closed cup
• Équipement de protection individuelle: dust mask type N95 (US), Eyeshields, Gloves